We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Retrospective process revalidation was deficient for your Active Pharmaceutical Ingredient batches that were used for revalidation although the corrective actions, which included changes in equipment and temperature, were not yet implemented in these batches.